valproic acid has been researched along with tubacin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brindisi, M; Brogi, S; Butini, S; Campiani, G; Gemma, S; Saraswati, AP | 1 |
| Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V | 1 |
| Ng, YK; Ong, WY; Tan, CS | 1 |
| Chiocca, EA; Cripe, TP; Fernandez, S; Glorioso, JC; Goins, WF; Grandi, P; Kasai, K; Kaufmann, JK; Lawler, S; Nakano, I; Nakashima, H; Nguyen, T; Okemoto, K; Otsuki, A; Speranza, MC; Wang, PY | 1 |
| Belmonte-Reche, E; Corpas-López, V; de Pedro, N; Díaz-Gavilán, M; Franco-Montalbán, F; Gómez-Vidal, JA; López-Viota, J; López-Viota, M; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Márquez, F; Pérez-Del Palacio, J | 1 |
1 review(s) available for valproic acid and tubacin
| Article | Year |
|---|---|
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction | 2022 |
4 other study(ies) available for valproic acid and tubacin
| Article | Year |
|---|---|
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.
Topics: Animals; Biomarkers; Cell Line; Epigenesis, Genetic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Mice; Protein Processing, Post-Translational; Rare Diseases | 2020 |
Epigenetic Regulation of Cytosolic Phospholipase A2 in SH-SY5Y Human Neuroblastoma Cells.
Topics: Anacardic Acids; Anilides; Benzamides; Cell Line, Tumor; Chromatin Immunoprecipitation; Deoxyadenosines; Epigenesis, Genetic; Fluorescent Antibody Technique; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Group IV Phospholipases A2; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; L-Lactate Dehydrogenase; Lysine; Neuroblastoma; Pyridines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thionucleosides; Valproic Acid | 2016 |
Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.
Topics: Acetylation; Acetyltransferases; Anilides; Brain Neoplasms; Capsid; Cell Line, Tumor; Cell Nucleus; Endocytosis; Glioma; Herpesvirus 1, Human; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; In Vitro Techniques; Interferon-beta; Lysosomes; Microtubule Proteins; Microtubules; Neoplasm Proteins; Oncolytic Virotherapy; Oncolytic Viruses; Protein Processing, Post-Translational; Protein Transport; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; RNA, Viral; Spheroids, Cellular; Tubulin; Valproic Acid; Virus Replication | 2015 |
A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis.
Topics: Administration, Oral; Anilides; Animals; Antiprotozoal Agents; Drug Delivery Systems; Female; Gold; Histone Deacetylase Inhibitors; Hydroxamic Acids; Leishmania infantum; Leishmaniasis, Visceral; Mice, Inbred BALB C; Mice, Inbred ICR; Nanoparticles; Valproic Acid; Vorinostat | 2019 |